STERIS plc (NYSE:STE) Stake Lowered by Pitcairn Co.

Pitcairn Co. trimmed its position in shares of STERIS plc (NYSE:STE) by 2.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,679 shares of the medical equipment provider’s stock after selling 50 shares during the period. Pitcairn Co.’s holdings in STERIS were worth $345,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. Avalon Trust Co purchased a new stake in shares of STERIS during the 4th quarter worth about $30,000. Human Investing LLC acquired a new position in STERIS in the fourth quarter worth approximately $31,000. Anfield Capital Management LLC increased its holdings in STERIS by 100.0% in the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock worth $37,000 after buying an additional 91 shares during the last quarter. Central Pacific Bank Trust Division raised its position in STERIS by 65.5% during the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock valued at $39,000 after acquiring an additional 76 shares in the last quarter. Finally, Manchester Capital Management LLC lifted its stake in STERIS by 182.7% in the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock valued at $44,000 after acquiring an additional 137 shares during the last quarter. Institutional investors and hedge funds own 94.69% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently commented on the stock. JMP Securities restated a “market outperform” rating and set a $265.00 price target on shares of STERIS in a research note on Thursday, February 6th. Stephens reissued an “overweight” rating and set a $240.00 target price on shares of STERIS in a research report on Thursday, February 6th. Finally, Piper Sandler raised their target price on STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a report on Monday, February 3rd. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $258.75.

STERIS Price Performance

Shares of STERIS stock opened at $213.16 on Monday. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32. The firm has a fifty day simple moving average of $223.23 and a 200-day simple moving average of $220.44. The stock has a market capitalization of $20.94 billion, a price-to-earnings ratio of 45.26 and a beta of 0.87. STERIS plc has a 1-year low of $197.82 and a 1-year high of $248.24.

STERIS (NYSE:STE) last released its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. On average, sell-side analysts expect that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, March 21st. Shareholders of record on Thursday, February 20th were issued a $0.57 dividend. This represents a $2.28 dividend on an annualized basis and a yield of 1.07%. The ex-dividend date was Thursday, February 20th. STERIS’s dividend payout ratio (DPR) is currently 48.41%.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.